21.10.2021 16:35

With Market Size Valued at $183.2 Billion by 2026, it`s Exciting Times for the Global Mobile Health Monitoring, Diagnostic Devices and Services Market


SAN FRANCISCO, Oct. 21, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Mobile Health Monitoring, Diagnostic Devices and Services - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

Global Mobile Health Monitoring, Diagnostic Devices and Services Market

Edition: 6; Released: April 2021
Executive Pool: 378
Companies: 46 - Players covered include Cardiac Science Corporation; CardioNet, Inc.; Cellnovo Group; LifeWatch AG; Medtronic, Inc.; Philips Healthcare; Telcare LLC; WellDoc, Inc. and Others.
Coverage: All major geographies and key segments
Segments: Diagnostic Medical Device and Service (Cardiac Monitors, Diagnostic Device, Diabetes Management Devices, Multi-Parameter Trackers, Other Diagnostic Medical Device and Services)
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry


Global Mobile Health Monitoring, Diagnostic Devices and Services Market to Reach $183.2 Billion by 2026
Amid the COVID-19 crisis, the global market for Mobile Health Monitoring, Diagnostic Devices and Services estimated at US$23.1 Billion in the year 2020, is projected to reach a revised size of US$183.2 Billion by 2026, growing at a CAGR of 40.6% over the analysis period. Cardiac Monitors, one of the segments analyzed in the report, is projected to record a 41.8% CAGR and reach US$46.1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Diagnostic Device segment is readjusted to a revised 33.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $10.4 Billion in 2021, While China is Forecast to Reach $29.7 Billion by 2026
The Mobile Health Monitoring, Diagnostic Devices and Services market in the U.S. is estimated at US$10.4 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$29.7 Billion by the year 2026 trailing a CAGR of 38.2% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 36.9% and 34.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 27.4% CAGR.

Diabetes Management Devices Segment to Reach US$88.9 Billion by the year 2026
In the global Diabetes Management Devices segment, USA, Canada, Japan, China and Europe will drive the 46.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$6.9 Billion in the year 2020 will reach a projected size of US$101.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. More

MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android

About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.

Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
Email: ZA@StrategyR.com

Join Our Expert Panel

Connect With Us on LinkedIn

Follow Us on Twitter

Journalists & Media

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/with-market-size-valued-at-183-2-billion-by-2026--its-exciting-times-for-the-global-mobile-health-monitoring-diagnostic-devices-and-services-market-301405552.html

SOURCE Global Industry Analysts, Inc.

Börse Stuttgart Anlegerclub

Heute im Fokus

Neue Virussorgen: DAX geht tiefrot ins Wochenende -- Ausverkauf in den USA -- Lufthansa fliegt vorerst weiter nach Südafrika -- Tesla verzichtet auf staatliche Förderung -- Software AG, K+S im Fokus

Apple macht iPhone in der Türkei über Nacht mehr als 25 Prozent teurer. Ocugen-Aktie: FDA stoppt Covaxin-Impfstoff. BioNTech prüft Wirksamkeit seines Impfstoffs gegen neue Corona-Variante. Nextcloud legt Beschwerde gegen Microsoft beim Bundeskartellamt ein. Kryptowährungen geben wegen neuer Virusvariante kräftig nach. Deutsche Bank: Entscheidend ob Impfstoffe gegen Variante wirken.


Sind Sie in Kryptowährungen wie Bitcoin, Ether & Co. investiert?

finanzen.net zero
finanzen.net zero



Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln